Correlation Between Caribou Biosciences and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Editas Medicine, you can compare the effects of market volatilities on Caribou Biosciences and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Editas Medicine.
Diversification Opportunities for Caribou Biosciences and Editas Medicine
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Caribou and Editas is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Editas Medicine go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Editas Medicine
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.36 times more return on investment than Editas Medicine. However, Caribou Biosciences is 1.36 times more volatile than Editas Medicine. It trades about -0.03 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.13 per unit of risk. If you would invest 299.00 in Caribou Biosciences on August 24, 2024 and sell it today you would lose (101.00) from holding Caribou Biosciences or give up 33.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Editas Medicine
Performance |
| Timeline |
| Caribou Biosciences |
| Editas Medicine |
Caribou Biosciences and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Editas Medicine
The main advantage of trading using opposite Caribou Biosciences and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| Editas Medicine vs. ZyVersa Therapeutics | Editas Medicine vs. Sonnet Biotherapeutics Holdings | Editas Medicine vs. Zura Bio Limited | Editas Medicine vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |